Germany’s Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.
German chemical and pharma group Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming. Merck said in a ...
14d
Stocktwits on MSNSpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even as its shares tumbled more than 14%, marking their worst weekly decline ...
Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...
Merck KGaA (MKGAY) said in its annual report this morning: “On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics (SWTX), Inc ...
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
Merck KGaA reaffirmed its strong performance in the healthcare sector in its FY 2024 earnings report, but provided little additional information on ongoing acquisition talks with SpringWorks ...
Barclays continues to see limited regulatory risk for Merck KGaA’s potential buyout of SpringWorks. It has an Overweight rating on SpringWorks with a $63 price target See what stocks are ...
Another reason: Merck KGaA, Darmstadt, Germany, has confirmed it is in advanced talks to acquire SpringWorks—a speculated reason why the company last week canceled a scheduled earnings call with ...
One of the most significant developments for SpringWorks is the ongoing merger and acquisition discussions with Merck KGaA. Analysts view this potential acquisition as strategically sound for ...
One of the most significant developments for SpringWorks is the ongoing merger and acquisition discussions with Merck KGaA. Analysts view this potential acquisition as strategically sound for several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results